Home > Topics > Sclerostin and LRP5

Sclerostin and LRP5

Citations 1-3 of 3 total displayed.

Most recent content (1 May 2010):

MEETING REPORTS
Systemic and Local Regulation of Skeletal Metabolism – Meeting Report from the IBMS Davos Workshop: Bone Biology & Therapeutics: March 14-19, 2010 in Davos, Switzerland: Jillian Cornish
IBMS BoneKEy 2010; 7: 187-189. [Full text] [PDF]

Past content (since Dec 2001):

Commentaries
The Promise of Sclerostin Inhibition for the Treatment of Osteoporosis: Michaela Kneissel
IBMS BoneKEy 2009; 6: 259-264. [Full text] [PDF]

Commentaries
LRP5 at the Crossroad of Human Genetics: Patricia Ducy
BoneKEy-Osteovision 2001; 1: 2001048. [Full text]

RSS feed for Sclerostin and LRP5

Topics Home

IBMS BoneKEy is published by the International Bone & Mineral Society which is solely responsible for the content of the site. IBMS accepts support from corporate sponsors in the form of unrestricted educational grants, however, the content of the site is not reviewed or influenced by corporate sponsors in any way. All editorial decisions are the sole responsibility of the IBMS BoneKEy editorial board and all original material is peer-reviewed.